Clemens A H Boersig
CIK 1455223 · View on SEC EDGAR ↗
Insider
First SEC filing: Oct. 31, 2018 · Latest: Oct. 31, 2018
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 20 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2022 | LIN | M | 518 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Feb. 23, 2022 | LIN | M | 518 | — | — | 2,793 Direct | +22.77% | Acquired | (price as of 2026-08-21) |
| Feb. 1, 2022 | EMR | F | 213 | $91.83 | $19,560 | 30,117 Direct | -0.70% | Disposed | 69.9% (price as of 2026-08-21) |
| May 13, 2021 | LIN | M | 625 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| May 13, 2021 | LIN | F | 46 | $254.61 | $11,712 | 2,275 Direct | -1.98% | Disposed | 91.6% (price as of 2026-08-21) |
| May 13, 2021 | LIN | M | 625 | — | — | 2,321 Direct | +36.85% | Acquired | (price as of 2026-08-21) |
| Feb. 22, 2021 | LIN | A | 511 | — | — | 511 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 2, 2021 | EMR | A | 1,787 | — | — | 30,330 Direct | +6.26% | Acquired | (price as of 2026-08-21) |
| Feb. 4, 2020 | EMR | A | 2,030 | — | — | 28,543 Direct | +7.66% | Acquired | (price as of 2026-08-21) |
| Feb. 5, 2019 | EMR | A | 2,264 | — | — | 26,513 Direct | +9.34% | Acquired | (price as of 2026-08-21) |
| Feb. 6, 2018 | EMR | A | 2,038 | — | — | 24,249 Direct | +9.18% | Acquired | (price as of 2026-08-21) |
| Feb. 7, 2017 | EMR | A | 2,248 | — | — | 22,211 Direct | +11.26% | Acquired | (price as of 2026-08-21) |
| Feb. 2, 2016 | EMR | A | 3,042 | — | — | 19,963 Direct | +17.98% | Acquired | (price as of 2026-08-21) |
| Feb. 3, 2015 | EMR | A | 2,381 | — | — | 16,921 Direct | +16.38% | Acquired | (price as of 2026-08-21) |
| Feb. 4, 2014 | EMR | A | 1,964 | — | — | 14,540 Direct | +15.62% | Acquired | (price as of 2026-08-21) |
| Feb. 5, 2013 | EMR | A | 2,199 | — | — | 12,576 Direct | +21.19% | Acquired | (price as of 2026-08-21) |
| Feb. 7, 2012 | EMR | A | 2,409 | — | — | 10,377 Direct | +30.23% | Acquired | (price as of 2026-08-21) |
| Feb. 1, 2011 | EMR | A | 1,957 | — | — | 7,968 Direct | +32.56% | Acquired | (price as of 2026-08-21) |
| Feb. 2, 2010 | EMR | A | 2,561 | — | — | 6,011 Direct | +74.23% | Acquired | (price as of 2026-08-21) |
| Feb. 3, 2009 | EMR | A | 3,450 | — | — | 3,450 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 23, 2022 | LIN | Restricted Stock Units | Ordinary Shares (518) | — | — | 518 | Disposed |
| May 13, 2021 | LIN | Restricted Stock Units | Ordinary Shares (625) | — | — | 625 | Disposed |
| Feb. 22, 2021 | LIN | Restricted Stock Units | Ordinary Shares (511) | — | — | 511 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 31, 2018 | LIN | Ordinary Shares | 979 | Direct |